Merieux Equity Partners
Jonathan Dupont is an experienced professional in the fields of venture capital and pharmaceuticals. Currently serving as an Associate at Merieux Equity Partners since June 2020, Jonathan has held multiple roles including Venture Capital Analyst and Business Analyst Junior. In addition to the role at Merieux, Jonathan invests in companies such as AcuSurgical, Neurinnov, and Mablink Bioscience. Previous experience includes positions in community pharmacy, sterilization of medical devices, geriatric orthopedic services, and quality assurance, with significant contributions to the reputation of the Quality Assurance department at BD. Jonathan holds a Master of Science in Biopharmaceutical Management from ESCP Business School and a degree in Pharmacy from Université Grenoble Alpes.
Merieux Equity Partners
Merieux Equity Partners is a multistage investment manager specialized in the healthcare & nutrition sectors via two dedicated platforms: Venture and Growth/Buyout. As an independent General Partner - registered under the French Financial Markets Authority AMF ("Autorité des Marchés Financiers") - Merieux Equity Partners currently manages 5 main funds, representing more than €1 billion of Commitments, and has supported over 45 companies in Europe and North America since its creation - in Venture Capital and Growth/Buyout. Our passion is to work alongside entrepreneurs and companies with an ambitious growth plan, offering them privileged access to our sector-expertise and cross-border experience. With a team of 24 full-time employees and 6 Senior Advisors, we strive to bring the best of our operational experience and privileged access to Merieux' industrial network.